Gentian Diagnostics AS (OSL:GENT) Shares Buyback Ratio % : 0.00 (As of Dec. 15, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gentian Diagnostics AS Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Gentian Diagnostics AS's current shares buyback ratio was 0.00%.

Gentian Diagnostics AS Shares Buyback Ratio % Historical Data

The historical data trend for Gentian Diagnostics AS's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gentian Diagnostics AS Shares Buyback Ratio % Chart

Gentian Diagnostics AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Get a 7-Day Free Trial

-0.04

-0.06

-0.07

Gentian Diagnostics AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Shares Buyback Ratio %	Get a 7-Day Free Trial															-	-	-	-	-

Gentian Diagnostics AS Shares Buyback Ratio % Calculation

Gentian Diagnostics AS's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(15.4223	-	15.4223)	/	15.4223
	=	0.00%

Gentian Diagnostics AS's Shares Buyback Ratio for the quarter that ended in Sep. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Jun. 2024 )	-	Shares Outstanding (EOP) (A: Sep. 2024 ))	/	Shares Outstanding (EOP) (A: Jun. 2024 )
	=	(15.4223	-	15.4223)	/	15.4223
	=	0.00%

Gentian Diagnostics AS Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Gentian Diagnostics AS's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Gentian Diagnostics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gentian Diagnostics AS (OSL:GENT) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bjornasveien 5, Moss, NOR, 1596

Website

https://www.gentian.com

Gentian Diagnostics AS operates as a medical diagnostics company in Norway. It develops and produces in-vitro diagnostic reagents (IVD) for use in medical diagnostics and research. Its portfolio and pipeline of reagents span areas of inflammations, severe infections, kidney diseases, heart failures, and veterinary healthcare. The company's product portfolio includes the Gentian Cystatin C Immunoassay, the GCAL circulating calprotectin immunoassay (IVDR), the Gentian Retinol Binding Protein (RBP), and the Gentian Canine CRP among others. Geographically, it generates a majority of its revenue from Europe followed by Asia and the United States of America.